|
MAPKSP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25820465157744E-11 |
| Normal-vs-Stage2 |
5.9954999998002E-07 |
| Normal-vs-Stage3 |
1.10511599871188E-12 |
| Normal-vs-Stage4 |
1.69952940609619E-12 |
| Stage1-vs-Stage2 |
2.495400E-01 |
| Stage1-vs-Stage3 |
3.962600E-01 |
| Stage1-vs-Stage4 |
2.793600E-02 |
| Stage2-vs-Stage3 |
1.535620E-01 |
| Stage2-vs-Stage4 |
1.259590E-02 |
| Stage3-vs-Stage4 |
1.646950E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.33399999999273E-05 |
| Normal-vs-Asian |
2.8619000502772E-09 |
| Caucasian-vs-AfricanAmerican |
4.547600E-01 |
| Caucasian-vs-Asian |
4.652600E-01 |
| AfricanAmerican-vs-Asian |
8.562600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.21804821573824E-15 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.562400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62747593179802E-12 |
| Normal-vs-Age(41-60Yrs) |
5.10702591327572E-15 |
| Normal-vs-Age(61-80Yrs) |
2.2030155477637E-12 |
| Normal-vs-Age(81-100Yrs) |
4.522200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.069000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.243200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.011600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.040200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.894800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.217600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.448200E-01 |
| Classical-VS-Follicular |
2.927600E-02 |
| Classical-VS-Other |
8.091600E-01 |
| Classical-VS-Normal |
2.4299007250761E-11 |
| Tall-VS-Follicular |
2.960200E-01 |
| Tall-VS-Other |
9.424000E-01 |
| Tall-VS-Normal |
4.14830000350364E-08 |
| Follicular-VS-Other |
6.256200E-01 |
| Follicular-VS-Normal |
1.45699999953841E-07 |
| Other-VS-Normal |
6.419300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.82169859594705E-13 |
| Normal-vs-N1 |
1.68010050316525E-12 |
| N0-vs-N1 |
1.147240E-01 |
|
|
